JPRN-jRCT1080223619未知1 期
DK-233(Rifampicin) Bioequivalence study -Bioequivalence of DK-233 150 mg capsules and DK-233 20 mg/ml syrup in healthy Japanese subjects
试验速览
- 阶段
- 1 期
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 45age old（—）
- 性别
- Male
入选标准
- •1)Japanese male
- •2)Aged 20 years to 45 years (inclusive), at the time of informed consent
- •3)Body mass index (BMI; calculated by body weight [kg]/height [m]2) in the range of >= 18.5 kg/m2 and < 25.0 kg/m2 at the screening examination
排除标准
- •1)Hypersensitivity or idiosyncratic reactions to a drug (such as penicillin allergy)
- •2)Presence or history of any drug abuse or of alcohol abuse etc.
研究者
相似试验
尚未招募
1 期
Comparative assessment of the absorption of a generic formulatons of darifenacin against the innovator darifenacin product in healthy volunteers.ACTRN12610000883011Center for Clinical Pharmacology Research Bdbeq S.A.24
已完成
不适用
Comparative bioequivalency study (pharmacokinetics-pharmacodynamics) of Variopeptyl® 11.25 mg and Diphereline® 11.25 mg in Patients with non-metastatic or metastatic prostate cancer VolunteersIRCT20170225032759N3Varian Pharmed Co80
招募中
不适用
Bioequivalence study of Dimethyl fumarate capsule manufactured by Zistdaru danesh company (Teczifuma 240mg) in Iranian healthy volunteersIRCT20200623047902N1Zistdaru danesh Co.24
未知
1 期
DMB-3111 phase IHealthy volunteersJPRN-jRCT2080222436Meiji Seika Pharma Co., Ltd.70
已完成
不适用
Bioequivalence study of Darifenacin 15 mg proloned-release tablets in healthy Thai volunteersBioequivalenc of generic Darifenacin PRTCTR20170512004All Research Co., Ltd.88